| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $3.47M | $3.44M | $7.87M | $9.07M | $6.75M |
| SG&A | $3.74M | $4.16M | $5.44M | $5.52M | $6.42M |
| Operating Income | -$9.85M | -$10.17M | -$17.12M | -$15.28M | -$28.81M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$11.63M | -$23.36M | -$4.00M | -$15.20M | -$29.89M |
| EPS (basic) | -8.6600 | -11.1500 | -5.3300 | -0.3900 | -0.8500 |
| EPS (diluted) | -8.6600 | -11.1500 | -5.3300 | -11.7400 | – |
| Shares (diluted) | $1.73M | $2.44M | $1.54M | $1.29M | – |